Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neural Correlates of Driving After Medical Cannabis Exposure
NCT03581058Phase 1Unknown
- Sponsor
- Unity Health Toronto
- Start
- Aug 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of cannabis in cannabis use disorder (CUD), sponsored by Unity Health Toronto. Primary endpoint: Change in neural activation on fMRI. Status: unknown.
02
Drugs
cannabis
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT03581058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03581058.